Loading...
XASX
SIG
Market cap20bUSD
Apr 03, Last price  
2.87AUD
1D
0.00%
1Q
3.24%
Jan 2017
122.48%
Name

Sigma Healthcare Ltd

Chart & Performance

D1W1MN
P/E
7,311.22
P/S
9.92
EPS
0.00
Div Yield, %
0.35%
Shrs. gr., 5y
-7.50%
Rev. gr., 5y
-3.53%
Revenues
3.32b
-9.24%
336,296,0002,194,552,0002,734,722,0002,994,119,0003,108,467,0003,261,166,0002,939,374,0002,878,233,0002,968,007,0002,973,466,0003,142,126,0003,461,104,0004,366,208,0004,094,440,0003,976,774,0003,244,264,0003,400,379,0003,446,164,0003,660,240,0003,322,058,000
Net income
5m
+148.98%
0104,848,000101,788,00077,154,00080,124,000-389,042,000-235,382,00049,172,00018,686,00053,536,00052,773,00050,502,00053,184,00055,059,00036,520,000-12,330,00043,529,000-7,239,0001,811,0004,509,000
CFO
42m
-70.60%
020,905,00034,552,00036,894,00000101,242,000145,771,00065,626,00079,647,00061,314,00032,151,000145,769,00071,181,0008,470,000200,625,000-13,125,000-46,280,000142,738,00041,965,000
Dividend
Oct 01, 20240.005 AUD/sh
Earnings
Sep 23, 2025

Profile

Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale and distribution of pharmaceutical products primarily in Australia. It operates approximately 1,200 branded and independent pharmacy stores under the Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave brands. The company also provides hospital pharmacy wholesale services; dose administration aid services to the aged care sector, community pharmacy sector, and in the home; technology solutions and data analytics; and product development and support for a range of private and exclusive label products, as well as supplies medical consumables and devices to a broad range of customers, including pharmacy aged care facilities, hospitals, and clinics. In addition, it offers contract logistics services to pharmaceutical manufacturers and other supplier partners. Sigma Healthcare Limited was founded in 1912 and is headquartered in Rowville, Australia.
URL
https://sigmahealthcare.com.au/
IPO date
Oct 30, 2002
Employees
156
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑012023‑012022‑012021‑012020‑012019‑012018‑012017‑012016‑01
Income
Revenues
3,322,058
-9.24%
3,660,240
6.21%
Cost of revenue
3,394,006
3,729,163
Unusual Expense (Income)
NOPBT
(71,948)
(68,923)
NOPBT Margin
Operating Taxes
3,313
2,435
Tax Rate
NOPAT
(75,261)
(71,358)
Net income
4,509
148.98%
1,811
-125.02%
Dividends
(9,981)
(14,960)
Dividend yield
0.91%
2.29%
Proceeds from repurchase of equity
396,117
879
BB yield
-36.17%
-0.13%
Debt
Debt current
9,789
12,944
Long-term debt
263,473
348,082
Deferred revenue
134,041
Other long-term liabilities
7,179
4,909
Net debt
(96,856)
326,993
Cash flow
Cash from operating activities
41,965
142,738
CAPEX
(4,718)
(29,399)
Cash from investing activities
5,734
(28,604)
Cash from financing activities
295,825
(116,941)
FCF
(24,536)
(8,239)
Balance
Cash
356,496
16,650
Long term investments
13,622
17,383
Excess cash
204,015
Stockholders' equity
917,960
529,448
Invested Capital
812,406
709,660
ROIC
ROCE
EV
Common stock shares outstanding
1,063,315
1,028,057
Price
1.03
62.20%
0.64
41.11%
Market cap
1,095,214
67.77%
652,816
-7.63%
EV
1,000,199
981,657
EBITDA
(43,625)
(38,587)
EV/EBITDA
Interest
16,303
14,407
Interest/NOPBT